Hemoadsorption Using CytoSorb<sup>®</sup> in Patients with Infective Endocarditis: A German-Based Budget Impact Analysis

Hemoadsorption Using CytoSorb<sup>®</sup> in Patients with Infective Endocarditis: A German-Based Budget Impact Analysis

A considerable number of infective endocarditis (IE) patients require cardiac surgery with an increased risk for postoperative sepsis. Intraoperative hemoadsorption may diminish the risk of postoperative hyperinflammation with potential economic implications for intensive care unit (ICU) occupation....

Full description

Bibliographic Details
Main Authors:	Cristina Rao, Franziska Preissing, Matthias Thielmann, Daniel Wendt, Zaki Haidari, Jurij Matija Kalisnik, Lothar Daake, Karl Traeger
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Series:	Journal of Cardiovascular Development and Disease
Subjects:	acute infective endocarditis extracorporeal techniques hemoadsorption cytosorb cardiopulmonary bypass surgery economic evaluation
Online Access:	https://www.mdpi.com/2308-3425/10/9/366

Similar Items

A Contemporary Review of the Use of Extracorporeal CytoSorb<sup>®</sup> Hemoadsorption Therapy in Patients with Infective Endocarditis
by: Anan Gong, et al.
Published: (2024-01-01)

Impact of CytoSorb Hemoadsorption Therapy on Fluid Balance in Patients with Septic Shock
by: Klaus Kogelmann, et al.
Published: (2024-01-01)

Use of CytoSorb® hemoadsorption column during prolonged cardiopulmonary bypass in complex cardiac surgery patient
by: Marianne Alarie, et al.
Published: (2022-07-01)

Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb<sup>®</sup>—Basics, Indications and Perspectives—A Scoping Review
by: Thomas Köhler, et al.
Published: (2021-11-01)

Hemoadsorption in ‘Liver Indication’—Analysis of 109 Patients’ Data from the CytoSorb International Registry
by: Klementina Ocskay, et al.
Published: (2021-11-01)

First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock
by: Klaus Kogelmann, et al.
Published: (2021-06-01)

Adjunctive Hemoadsorption Therapy with CytoSorb in Patients with Septic/Vasoplegic Shock: A Best Practice Consensus Statement
by: Steffen Mitzner, et al.
Published: (2023-11-01)

Use of CytoSorb© Hemoadsorption in Patients on Veno-Venous ECMO Support for Severe Acute Respiratory Distress Syndrome: A Systematic Review
by: Ali Akil, et al.
Published: (2022-10-01)

Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective ‘Genetic’ Matched Analysis
by: Christopher Rugg, et al.
Published: (2020-11-01)

Single-Centre Retrospective Evaluation of Intraoperative Hemoadsorption in Left-Sided Acute Infective Endocarditis
by: Jurij Matija Kalisnik, et al.
Published: (2022-07-01)

CytoSorb in the management of severe septic shock after coronary artery bypass graft surgery
by: Amit Prakash, et al.
Published: (2020-01-01)

Hemoadsorption by CytoSorb in septic patients: a case series
by: Klaus Kogelmann, et al.
Published: (2017-03-01)

CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo
by: Aron Jansen, et al.
Published: (2023-03-01)

Experience of using an extracorporeal cytokine hemoadsorber (CytoSorb®) in systemic inflammatory response syndrome after heart transplantation
by: Kewal Krishan, et al.
Published: (2020-01-01)

Hemoadsorption during Cardiopulmonary Bypass in Patients with Endocarditis Undergoing Valve Surgery: A Retrospective Single-Center Study
by: David Santer, et al.
Published: (2021-02-01)

Impact of Continuous Kidney Replacement Therapy and Hemoadsorption with CytoSorb on Antimicrobial Drug Removal in Critically Ill Children with Septic Shock: A Single-Center Prospective Study on a Pediatric Cohort
by: Gabriella Bottari, et al.
Published: (2023-08-01)

CytoSorb® therapy: a new approach to treat critically ill patients with COVID-19 – a retrospective study
by: K. Patil, et al.
Published: (2023-06-01)

Technical Note: Novel Use of CytoSorb™ Haemadsorption to Provide Wound Healing Support in Case of Severe Burn Trauma via Reduction of Hyperbilirubinaemia
by: Katarzyna Rachunek, et al.
Published: (2021-12-01)

Extracorporeal hemoadsorption therapy as a potential therapeutic option for rapid removal of Apixaban in high risk-surgical patients: a case report
by: Vittorio Dalmastri, et al.
Published: (2023-07-01)

Paediatric patient with dengue fever and associated multi-organ dysfunction syndrome (MODS) receiving hemoadsorption using Cytosorb® – A case report on clinical experience
by: S. Kumar, et al.
Published: (2020-05-01)

Post VV-ECMO Weaning Hyperinflammation—Can Prophylactic Hemoadsorption Treatment Prevent Complications?
by: Pedja Kovacevic, et al.
Published: (2023-10-01)

Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study
by: Willem Pieter Brouwer, et al.
Published: (2019-09-01)

Cytokine hemoadsorption with CytoSorb® in post-cardiac arrest syndrome, a pilot randomized controlled trial
by: Céline Monard, et al.
Published: (2023-01-01)

CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
by: Patrick M. Honore, et al.
Published: (2020-07-01)

Impact of CytoSorb® on interleukin-6 in cardiac surgery
by: Daniela Geisler, et al.
Published: (2023-08-01)

Cytosorb use in postoperative treatment of a patient with infective endocarditis
by: Marković Dejan, et al.
Published: (2018-01-01)

Removal of Apixaban during Emergency Cardiac Surgery Using Hemoadsorption with a Porous Polymer Bead Sorbent
by: Kambiz Hassan, et al.
Published: (2022-10-01)

Effective Apixaban removal using hemoadsorption during emergent open-heart surgery: a case report and narrative literature review
by: Vitor Mendes, et al.
Published: (2024-04-01)

Antithrombotic drug removal with hemoadsorption during off-pump coronary artery bypass grafting
by: Helmut Mair, et al.
Published: (2024-04-01)

Hemoadsorption in Complex Cardiac Surgery—A Single Center Experience
by: Murali Manohar, et al.
Published: (2022-11-01)

A single centre experience with CytoSorb® as an adjunct therapy in critically ill patients with sepsis: a case series
by: H. Gajera, et al.
Published: (2023-06-01)

Pharmacokinetics of anti-infective agents during CytoSorb hemoadsorption
by: Antoine G. Schneider, et al.
Published: (2021-05-01)

CytoSorb in patients with coronavirus disease 2019: A rapid evidence review and meta-analysis
by: Shilin Wei, et al.
Published: (2023-01-01)

Effect of CytoSorb Coupled with Hemodialysis on Interleukin-6 and Hemodynamic Parameters in Patients with Systemic Inflammatory Response Syndrome: A Retrospective Cohort Study
by: Vanja Persic, et al.
Published: (2022-12-01)

Hemoadsorption in the critically ill-Final results of the International CytoSorb Registry.
by: Fatime Hawchar, et al.
Published: (2022-01-01)

Intraoperative Hemoadsorption (Cytosorb™) during Open Thoracoabdominal Aortic Repair: A Pilot Randomized Controlled Trial
by: Panagiotis Doukas, et al.
Published: (2023-01-01)

Use of CytoSorb therapy to treat critically ill coronavirus disease 2019 patients: a case series
by: Yatin Mehta, et al.
Published: (2021-09-01)

Does adjunctive hemoadsorption provide benefit in the management of ischemia–reperfusion syndrome following near-drowning? A case report
by: Pedja Kovacevic, et al.
Published: (2024-04-01)

Use of CytoSorb in the emergency department-high dependency unit: A case report and a mini review
by: Emanuela Biscardi, et al.
Published: (2021-12-01)

Role of Hemoperfusion With CytoSorb Associated With Continuous Kidney Replacement Therapy on Renal Outcome in Critically III Children With Septic Shock
by: Gabriella Bottari, et al.
Published: (2021-08-01)